Science Explorer Interactive view Map
Company · Jeonju · South Korea

JINIS Biopharmaceuticals (South Korea)

jinis.co.kr/enROR OpenAlex
Research works
25
▲ 96% vs 2013–17
Citations
550
21.9 per fractional work
Top-10% rate
11.5%
record average 16.5%
Open access
78%
world 28%

Not ranked overall: JINIS Biopharmaceuticals (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 3.56× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.96× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 0.65× its world share, 0 worksImmunology and Micro…Computer Science: 0.59× its world share, 0 worksComputer ScienceEngineering: 0.20× its world share, 0 worksEngineeringEnvironmental Science: 0.93× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.26× its world share, 0 worksMaterials ScienceDentistry: 3.17× its world share, 0 worksDentistryHealth Professions: 0.58× its world share, 0 worksHealth ProfessionsMedicine: 1.37× its world share, 2 worksMedicineNursing: 7.84× its world share, 0 worksNursingVeterinary: 28.25× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 1.43× its world share, 0 worksBusiness, Management…Social Sciences: 0.09× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 28.2×. Every wedge is a field page.

Which keywords describe research at JINIS Biopharmaceuticals (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Oxidative Stress, Cancer Therapy, Genome Engineering, RNA-Guided, Metabolism, Metabolic Syndrome and Neurodegeneration.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 11 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 11 words, with their numbers
  1. Inflammation2▲ 4.3×13 topics
  2. Oxidative Stress2▲ 4.9×8 topics
  3. Cancer Therapy2▲ 9.4×4 topics
  4. Genome Engineering1▲ 86×1 topic
  5. Metabolic Syndrome1▲ 6.0×5 topics
  6. Metabolism1▲ 7.7×6 topics
  7. RNA-Guided1▲ 86×1 topic
  8. Cancer1▲ 3.1×8 topics
  9. Epidemiology1◆ 1.05×9 topics
  10. Gut Microbiota1▲ 13×2 topics
  11. Neurodegeneration1▲ 15×5 topics

Which research topics does JINIS Biopharmaceuticals (South Korea) publish most on?

By volume in 2022–2025: CRISPR and Genetic Engineering, Animal Behavior and Welfare Studies, Plant tissue culture and regeneration and Chromosomal and Genetic Variations.

CRISPR and Genetic Engin…1CRISPR and Genetic Engineering: 1 fractional worksAnimal Behavior and Welf…0Animal Behavior and Welfare Studies: 0 fractional worksPlant tissue culture and regeneration: 0 fractional worksChromosomal and Genetic Variations: 0 fractional worksPlatelet Disorders and T…0Platelet Disorders and Treatments: 0 fractional worksBanking, Crisis Management, COVID-19 Impact: 0 fractional worksHeparin-Induced Thrombocytopenia and Thrombosis: 0 fractional worksCorporate Finance and Go…0Corporate Finance and Governance: 0 fractional worksSARS-CoV-2 and COVID-19 Research: 0 fractional worksBusiness and Economic Development: 0 fractional works
Molecular BiologySmall AnimalsPlant ScienceHematology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CRISPR and Genetic Engineering Molecular Biology 1 works
  2. 2 Animal Behavior and Welfare Studies Small Animals 0 works
  3. 3 Plant tissue culture and regeneration Molecular Biology 0 works
  4. 4 Chromosomal and Genetic Variations Plant Science 0 works
  5. 5 Platelet Disorders and Treatments Hematology 0 works
  6. 6 Banking, Crisis Management, COVID-19 Impact General Agricultural and Biological Sciences 0 works
  7. 7 Heparin-Induced Thrombocytopenia and Thrombosis Surgery 0 works
  8. 8 Corporate Finance and Governance Accounting 0 works
  9. 9 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  10. 10 Business and Economic Development Management, Monitoring, Policy and Law 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available78.3%not open21.7%

World: 28% of research is openly available.

with international co-authors31.9%domestic only68.1%

World: 19% is written across borders.

How has JINIS Biopharmaceuticals (South Korea)'s research output changed?

Output in 2018–2022 was 96% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Jeonju

All research institutions in Jeonju

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.